Tag Archives: Food and Drug Administration

New Push Ties Cost of Drugs to How Well They Work

Source: Wall Street Journal As drug costs rise, Express Scripts seeks new payment deals for some cancer medications ENLARGE Tarceva has shown a smaller benefit in pancreatic cancer than in lung cancer. PHOTO: JB REED/BLOOMBERG NEWS By PETER LOFTUS May … Continue reading

Posted in Economia de la Salud, Medicamentos, Política Sanitaria, tratamiento | Tagged , , , , , , , | 2 Comments

SGLT2 inhibitors: Drug Safety Communication – FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood

  ISSUE: FDA is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization. FDA is continuing … Continue reading

Posted in Medicamentos, Prevencion cuaternaria, tratamiento | Tagged , , , , , , , , , | Leave a comment

Cheap blindness drug should be made widely available, says WHO

Source: The Guardian (UK) World Health Organisation rejects expensive licensed drug Lucentis to be added to list for all countries in favour of much cheaper Avastin, not yet available in UK Avastin, primarily a bowel cancer drug, is similar to … Continue reading

Posted in Noticias, oftalmologia, tratamiento | Tagged , , , , , , , , , , | 2 Comments

Nuevos medicamentos para la hepatitis C, ¿valen lo que cuestan? (I: Análisis)

Via: Nadaesgratis.es  por PEDRO REY BIEL el 27/01/2015 De Pedro Rey Biel y Javier Rey del Castillo La industria farmacéutica es el principal inductor del aumento descontrolado del gasto sanitario en la mayoría de los países desarrollados, lo que se … Continue reading

Posted in Hepatology | Tagged , , , , , , , , , , | Leave a comment

Terapia antitrombótica

Via: Galo Sanchez Las guías clínicas de la Sociedad europea de cardiología, en 2011, y de la American Heart Association, en 2009, aconsejan que todas las personas que han padecido un IAM reciban terapia antitrombótica con aspirina y clopidogrel durante … Continue reading

Posted in Cardiology | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Safety Patients: Olmesartan

Olmesartan: Drug Safety Communication – FDA Review Finds Cardiovascular Risks for Diabetics Not Conclusive Includes: Benicar, Benicar HCT, Azor, Tribenzor, and Generics AUDIENCE: Cardiology, Pharmacy, Family Practice, Endocrinology ISSUE: FDA has completed its safety review and has found no clear … Continue reading

Posted in safety patient, seguridad en el paciente | Tagged , , , , , , , , | Leave a comment